Sanjiv K. Patel's most recent trade in Relay Therapeutics Inc was a trade of 42,769 Common Stock done at an average price of $3.0 . Disclosure was reported to the exchange on April 23, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 2.97 per share. | 23 Apr 2025 | 42,769 | 840,320 | - | 3.0 | 127,024 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 2.97 per share. | 23 Apr 2025 | 18,653 | 821,667 | - | 3.0 | 55,399 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 332,465 | 958,413 | - | 0 | Common Stock | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.85 per share. | 11 Feb 2025 | 140,182 | 625,948 | - | 3.9 | 539,701 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.70 per share. | 11 Feb 2025 | 75,324 | 883,089 | - | 3.7 | 278,699 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.78 per share. | 21 Jan 2025 | 125,000 | 199,548 | - | 4.8 | 597,500 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.52 per share. | 21 Jan 2025 | 125,000 | 449,548 | - | 4.5 | 565,000 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.80 per share. | 21 Jan 2025 | 125,000 | 324,548 | - | 4.8 | 600,000 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 1,105,000 | 1,105,000 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.00 per share. | 16 Dec 2024 | 100,000 | 574,548 | - | 5 | 500,000 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 25 Jul 2024 | 50,000 | 816,130 | - | 5.0 | 252,000 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jul 2024 | 50,000 | 518,779 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 9.16 per share. | 25 Jul 2024 | 50,000 | 766,130 | - | 9.2 | 458,000 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jul 2024 | 36,706 | 482,073 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 9.07 per share. | 25 Jul 2024 | 36,706 | 766,130 | - | 9.1 | 332,923 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 25 Jul 2024 | 36,706 | 802,836 | - | 5.0 | 184,998 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 5.54 per share. | 30 Jun 2024 | 2,108 | 766,130 | - | 5.5 | 11,678 | Common Stock |
| Relay Therapeutics Inc | Patel Sanjiv K. | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 762,360 | 764,022 | - | 0 | Common Stock | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 20.98 per share. | 07 Feb 2023 | 14,000 | 0 | - | 21.0 | 293,720 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 07 Feb 2023 | 14,000 | 14,000 | - | 5.0 | 70,560 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 21.45 per share. | 07 Feb 2023 | 14,000 | 0 | - | 21.5 | 300,300 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 07 Feb 2023 | 14,000 | 14,000 | - | 5.0 | 70,560 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 07 Feb 2023 | 14,000 | 14,000 | - | 5.0 | 70,560 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 20.55 per share. | 07 Feb 2023 | 14,000 | 0 | - | 20.6 | 287,700 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2023 | 14,000 | 596,779 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2023 | 14,000 | 582,779 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2023 | 14,000 | 568,779 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 701,680 | 701,680 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 701,680 | 701,680 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 28,000 | 610,779 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 28,000 | 638,779 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 28,000 | 666,779 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 20.02 per share. | 17 Jan 2023 | 28,000 | 254,554 | - | 20.0 | 560,560 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 17 Jan 2023 | 28,000 | 282,554 | - | 5.0 | 141,120 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 20.87 per share. | 17 Jan 2023 | 28,000 | 254,554 | - | 20.9 | 584,360 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 17 Jan 2023 | 28,000 | 282,554 | - | 5.0 | 141,120 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 20.23 per share. | 17 Jan 2023 | 28,000 | 254,554 | - | 20.2 | 566,440 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 17 Jan 2023 | 28,000 | 282,554 | - | 5.0 | 141,120 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 254,554 | 687,355 | - | 0 | Common Stock | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 254,554 | 0 | - | 0 | Common Stock | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2022 | 18,175 | 0 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 08 Nov 2022 | 18,175 | 254,554 | - | 20 | 363,500 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 08 Nov 2022 | 18,175 | 272,729 | - | 4.1 | 74,881 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 08 Nov 2022 | 14,000 | 268,554 | - | 4.1 | 57,680 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2022 | 14,000 | 18,175 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 20.18 per share. | 08 Nov 2022 | 14,000 | 254,554 | - | 20.2 | 282,520 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2022 | 9,825 | 694,779 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 08 Nov 2022 | 9,825 | 254,554 | - | 20 | 196,500 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 08 Nov 2022 | 9,825 | 264,379 | - | 5.0 | 49,518 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 21.18 per share. | 11 Oct 2022 | 14,000 | 254,554 | - | 21.2 | 296,520 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Oct 2022 | 14,000 | 32,175 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Oct 2022 | 14,000 | 46,175 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Oct 2022 | 14,000 | 60,175 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 20.58 per share. | 11 Oct 2022 | 14,000 | 254,554 | - | 20.6 | 288,120 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 11 Oct 2022 | 14,000 | 268,554 | - | 4.1 | 57,680 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 11 Oct 2022 | 14,000 | 268,554 | - | 4.1 | 57,680 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 21.36 per share. | 11 Oct 2022 | 14,000 | 254,554 | - | 21.4 | 299,040 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 11 Oct 2022 | 14,000 | 268,554 | - | 4.1 | 57,680 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 13 Sep 2022 | 14,000 | 268,554 | - | 4.1 | 57,680 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 23.47 per share. | 13 Sep 2022 | 14,000 | 254,554 | - | 23.5 | 328,580 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2022 | 14,000 | 74,175 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2022 | 14,000 | 88,175 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2022 | 14,000 | 102,175 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 23.80 per share. | 13 Sep 2022 | 14,000 | 254,554 | - | 23.8 | 333,200 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 13 Sep 2022 | 14,000 | 268,554 | - | 4.1 | 57,680 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.45 per share. | 13 Sep 2022 | 14,000 | 254,554 | - | 25.5 | 356,300 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 13 Sep 2022 | 14,000 | 268,554 | - | 4.1 | 57,680 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 14.24 per share. | 30 Jun 2022 | 814 | 254,554 | - | 14.2 | 11,591 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Apr 2022 | 28,000 | 144,175 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 31.80 per share. | 12 Apr 2022 | 28,000 | 253,740 | - | 31.8 | 890,400 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 12 Apr 2022 | 28,000 | 281,740 | - | 4.1 | 115,360 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 12 Apr 2022 | 14,000 | 267,740 | - | 5.0 | 70,560 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Apr 2022 | 14,000 | 704,604 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Apr 2022 | 14,000 | 116,175 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Apr 2022 | 14,000 | 718,604 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Apr 2022 | 14,000 | 130,175 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 30.51 per share. | 12 Apr 2022 | 14,000 | 253,740 | - | 30.5 | 427,140 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 30.51 per share. | 12 Apr 2022 | 14,000 | 253,740 | - | 30.5 | 427,140 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 12 Apr 2022 | 14,000 | 267,740 | - | 4.1 | 57,680 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 31.94 per share. | 12 Apr 2022 | 14,000 | 253,740 | - | 31.9 | 447,160 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 12 Apr 2022 | 14,000 | 267,740 | - | 5.0 | 70,560 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 31.96 per share. | 12 Apr 2022 | 14,000 | 253,740 | - | 32.0 | 447,440 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 12 Apr 2022 | 14,000 | 267,740 | - | 4.1 | 57,680 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 527,140 | 527,140 | - | - | Stock Option (Right to Buy) | |
| Prothena Corporation plc | Sanjiv K. Patel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2021 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2021 | 325,000 | 325,000 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Mar 2021 | 150,000 | 674,548 | - | 0 | Common Stock | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Mar 2021 | 150,000 | 253,082 | - | 0 | Common Stock | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2020 | 753,804 | 753,804 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 20 Jul 2020 | 25,000 | 403,082 | - | 20 | 500,000 | Common Stock |